Leap Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to the development of groundbreaking cancer therapies. The company specializes in precision medicine, with a robust pipeline of innovative treatments targeting specific oncogenic pathways to address significant unmet medical needs in oncology. By leveraging its expertise and commitment to advancing cancer care, Leap Therapeutics aims to improve patient outcomes and position itself as a key player in the evolving healthcare landscape.
Click "Analyze" to generate stock analysis
LPTX Price Trend and Signals
LPTX Option Volumes & Open Interests (aggregated)
LPTX Put Call Ratios and IV (aggregated)
LPTX Financials
2025-10-16Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.